knowledge -WSS

knowledge

author：knowledge 2025-09-03 03:32:26 - browse：68

The Food and Drug Administration on Tuesday approved brexanolone, the first drug specifically targeted to treat postpartum depression — the most common complication of childbirth. Yet it’s a condition that often goes untreated because new mothers fear being stigmatized if they report symptoms.

Brexanolone is the first drug developed by and approved from Sage Therapeutics. The Cambridge, Mass.-based biotech company will market the new medicine under the brand name Zulresso.

“This approval is important for postpartum depression patients and it’s important for our company. It’s rare in your career when you can introduce a new medicine that is different from what’s out there,” said Sage CEO Jeff Jonas.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Biogen Alzheimer’s drug launch off to slow start

WSS

EU fines Illumina $475 million over Grail acquisition

A Greenpeace activist is fined for crash

For Medicare Advantage, Democrats want stronger protections around AI

Britney Spears to release memoir, 'The Woman In Me,' later this year

France's anti

Companies helping big Covid

entertainment

knowledge

knowledge

ChatGPT in medicine: STAT answers readers' burning questions

PhRMA lawsuit over Medicare drug price negotiation tossed

Activists slam private health insurers over coverage restrictions

A disappointing year of Humira biosimilars

Tori Bowie and the unacceptable rates of Black maternal death

How are insurers handling Leqembi and related scans?

Walensky prepares to leave CDC — and Congress — behind

The dental labor crisis is a moment of opportunity

What does generative AI mean for health care? We asked experts

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

explore

Is there an 'orca uprising'? Like orcas themselves, the answer is complex.

The debate over Covid

Sickle cell gene therapy cures need to be accessible in Africa

To avoid data mishandling cases, universities eye AI and other tools

Iran's president begins a rare visit to Africa 'to promote economic diplomacy'

Key House Republican on health care plans exit from Congress

knowledge

focus

explore

focus